ArticleMolecular genetics & genomic medicine2020

Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experience.

Rita Fischetto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.